Pharmacological manipulation of the glutamate transporter system in health and disease

Wilkie, Crystal M. (2019) Pharmacological manipulation of the glutamate transporter system in health and disease. Masters thesis, Memorial University of Newfoundland.

[img] [English] PDF - Accepted Version
Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission.

Download (1MB)


Glutamate transporter-1 (GLT-1) is the main glutamate transporter in the brain. Dysfunctional GLT-1 has been suggested to cause glutamate uptake impairments in Huntington disease (HD). It is thought that simply increasing GLT-1 expression can increase glutamate uptake in the brain. However, the functional effect of increasing GLT-1 expression in HD or the healthy brain has not been studied. We increased GLT-1 expression using two compounds, ceftriaxone and LDN/OSU-0212320 (LDN), and used the iGluSnFR technique to visualize glutamate dynamics in real-time. We found an impairment in glutamate uptake in the HD hippocampus in mice that was surprisingly not alleviated by ceftriaxone treatment. Furthermore, we found that increasing GLT-1 expression through ceftriaxone or LDN treatment in the healthy brain had no effect on glutamate uptake. These results suggest that increasing glutamate uptake is much more complex than just increasing GLT-1 expression.

Item Type: Thesis (Masters)
Item ID: 14047
Additional Information: Includes bibliographical references (pages 71-93).
Keywords: Huntington Disease, glutamate, GLT-1, ceftriaxone, LDN/OSU-0212320
Department(s): Medicine, Faculty of > Biomedical Sciences
Date: October 2019
Date Type: Submission
Medical Subject Heading: Huntington Disease; Receptors, Glutamate; Excitatory Amino Acid Transporter 2.

Actions (login required)

View Item View Item


Downloads per month over the past year

View more statistics